In agreement with our hypothesis, IPA analysis based on our phosphoprotein profiling data shows that ERK/MAPK and JAK/STAT, which are also downstream of BCR::ABL1, are the top signaling pathways negatively affected in gallic acid-treated CML cells. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.